概括
本案例研究突出了药物诱导的低血症,通常是由不适当的抗尿激素分泌 (SIADH) 综合征引起的. 迅速治疗,包括液体限制和药物调整,使患者完全康复.
科学领域:
- 内部医学 内部医学
- 临床药理学 临床药理学
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 低血是与药物相关的频繁的电解质失衡,可能导致严重的健康问题.
- 不适当的抗尿激素分泌综合征 (SIADH) 是与药物相关的低血的主要原因.
研究的目的:
- 为了呈现一种由奎平引起的SIADH二次性低血症病例.
- 强调早期SIADH识别和管理在服用他平的患者中的重要性.
主要方法:
- 一个53岁的病人的病例报告呈现出不安,尿急,口渴和困惑.
- 诊断低血的情况.
- 治疗包括限制液体和减少引起药物 (quetiapine).
主要成果:
- 这位患者被诊断为低血症.
- 在限制液体和调整药物后,患者完全康复.
- 这一案例证明了奎平可能诱导SIADH的潜力.
结论:
- SIADH可以由奎胺诱导,导致低血症.
- 早期诊断和适当的治疗,包括流体管理和药物审查,对于预防SIADH严重后果至关重要.
相关概念视频
Drug Therapy
32
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
32
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
52
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
52
Psychosis: Goals of Pharmacotherapy
98
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
98
Antiepileptic Drugs: Potassium Channel Activators
136
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
136
Sedatives and Hypnotics Drugs: Miscellaneous Agents
132
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
132
Antidepressant Drugs: MAOIs and Other Agents
170
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
170


